Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype

EuPA Open Proteom. 2016 Jan 16:10:42-49. doi: 10.1016/j.euprot.2016.01.006. eCollection 2016 Mar.

Abstract

Malignant pleural mesothelioma (MPM) is a rare cancer originated from pleural mesothelial cells. MPM has been associated with long-term exposure to asbestos. In this work we performed a comparative proteomic analysis of biphasic pleural mesothelioma (B-PM). Tissue biopsies were obtained from 61 patients who were subjected to a diagnostic thoracoscopy. 2D/MS based approach was used for proteomic analysis. The 22 proteins found differentially expressed in B-PM, with respect to benign, were analyzed by Ingenuity Pathways Analysis and compared with those obtained for epitheliod pleural mesothelioma (E-PM). A different activation of transcription factors, proteins and cytokines were observed between two subtypes.

Keywords: Biphasic; Epithelioid; Mesothelioma; Nrf2; Proteomics; Serum amyloid.